February 9, 2024 News by Margarida Maia, PhD Crocin supplement seen to reduce signs of inflammation in MS Taking a two-month supplement of crocin, an antioxidant found in the cooking spice saffron, helped to reduce signs of inflammation in people with multiple sclerosis (MS) who took part in a small study in Iran. However, crocin had no effect on symptoms of depression or anxiety compared with a…
February 25, 2019 News by Alberto Molano, PhD Study Indicates Possible Correlation Between Nutritional Status, MS Multiple sclerosis (MS) patients eat a more limited diet, with a lower average of 31 nutrients, including zinc, thiamin, and iron, when compared with healthy controls, a study shows. Blood tests also showed that MS patients had significantly lower iron levels, a different fatty acid composition in their red blood…
February 19, 2019 News by Santiago Gisler Participants Sought for Clinical Trial Studying Effects of Lipoic Acid on Progressive MS A clinical trial to test the effects of antioxidant treatment with lipoic acid on progressive forms of multiple sclerosis (MS) is recruitingĀ 118 participants at seven sites in North America. The study sites include: Birmingham, Alabama; Burlington, Vermont; Ā Portland, Oregon; Salt Lake City, Utah; Seattle, Washington; Washington, D.C., and;…
March 9, 2018 News by Patricia Silva, PhD NIH Trial Confirms Raxone’s Safety Profile in PPMS, Santhera Reports An exploratory Phase 1/2 clinical trial in primary progressive multiple sclerosis (PPMS) conducted at the National Institutes of Health (NIH) confirms the safety profile of Raxone (idebenone)Ā at a dose of 2,250 mg daily over two years. But no difference in effectiveness was found between the Raxone-treated group and…
July 10, 2017 Columns by Ed Tobias MS News That Caught My Eye: Young Patients Quit DMDs, Antioxidant to Slow Brain Decline, Interview with Top Ocrevus Doc, and Why Don’t I Smell That? In case you missedĀ them, here are some news stories that appeared in MS News Today that caught my eye over the past week. Younger MS Patients Who Are Hospitalized May Be at Higher Risk of Quitting Treatment, Study Reports Why would young patients, whose MS is…
September 19, 2016 News by Patricia Silva, PhD #ECTRIMS2016 – Antioxidant Lipoic Acid Appears to Slow SPMS Patients’ Neurodegeneration A pilot study exploring the antioxidant lipoic acid in patients with secondary progressive multiple sclerosis (SPMS) demonstrated that treatment for two years reduced the speed of brain tissue loss and improved the patients’ walking speed. The surprising finding was presented during the āNew directions in progressive MS researchā…
August 4, 2016 News by Charles Moore Antioxidant Therapies Seen as Promising Approach in Treating MS and Like Diseases A review article published in the British Journal of Pharmacology assesses antioxidant approaches for treating neurodegenerative disorders such as multiple sclerosis, Alzheimer’s, Parkinson’s, and amyotrophic lateral sclerosis (ALS). The review,Ā “Microglia antioxidant systems and redox signalling,”Ā notes that certain compounds associated with oxidative stress appear to be promising…
June 21, 2016 News by Patricia Silva, PhD GeneFo Partners with MitoQ to Offer Energy Supplement at Discount to MS Community GeneFo, a social-medical community that connects patients with multiple sclerosis (MS) and offers free in-house medical consulting, recently announced a partnershipĀ withĀ MitoQ, a New Zealand-based company focused on mitochondrial health. MitoQ is a mitochondria-targeted antioxidant supplement thatĀ mayĀ help to alleviate common symptomsĀ in MS. MS, a chronic disease of the central…
July 8, 2015 News by Maureen Newman Mitochondria May Play a Role in MS Development and Progression Recent attention to the role of mitochondria in the etiology of multiple sclerosis (what causes the disease) suggests that mitochondrial defects and mitochondrial structural and functional changes may contribute to the disease. Researchers studying mitochondria in multiple sclerosis believe abnormalities in mitochondrial dynamics impact cellular pathways such as inflammation and…